<DOC>
	<DOCNO>NCT02082782</DOCNO>
	<brief_summary>Irreversible electroporation ( IRE ) new , minimal-invasive image-guided treatment method tumor amenable surgical resection thermal ablation , due vicinity near vital structure vessel bile duct . With IRE , multiple electrical pulse apply tumorous tissue . These pulse alter exist transmembrane potential cell membrane , create 'nanopores ' , cell dy loss homeastasis . The purpose study investigate efficacy percutaneous open IRE treatment patient colorectal liver metastasis ( CRLM ) unsuitable resection thermal ablation due vicinity vulnerable structure vessel bile duct . Other objective safety , feasibility ( technical success ) image characteristic follow-up ( PET- ) CT PET-MRI value image modality dianosing local site recurrence ( LSR ) residual disease ( RD ) . 29 patient histologically confirm colorectal carcinoma present unresectable thermally ablative CRLM &lt; 3.5cm suitable IRE undergo percutaneous open irreversible electroporation tumor use CT ultrasound guidance . All ( serious ) adverse event register . One day post-IRE MRI perform assess technical success . Follow-up consist frequent ( PET- ) CT ( PET- ) MRI scan localize residual recurrent disease . Overall technique effectiveness determine 1 year treatment . The investigator hypothesize IRE central CRLM lead good tumor control without cause severe complication .</brief_summary>
	<brief_title>Efficacy Irreversible Electroporation ( IRE ) Central Colorectal Liver Metastases</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>Histological cytological documentation primary colorectal tumor ; Previous induction chemotherapy due unresectability ; intra extrahepatic disease progression induction chemotherapy ; OR Previous chemotherapy CRLM , present renew CRLM unsuitable resection thermal ablation ; Liver metastases F18FDG PET avid visible ceCT , size ≤ 3,5 cm eligible resection thermal ablation due location close vessel bile duct ; Age 18 year ; ASA classification 0 3 ; Adequate bone marrow , liver renal function assess follow laboratory requirement conduct within 7 day prior definite inclusion : Hemoglobin ≥ 5.6 mmol/L ; Absolute neutrophil count ( ANC ) ≥ 1,500/mm3 ; Platelet count ≥ 100*109/l ; Total bilirubin ≤ 1.5 time upper limit normal ( ULN ) ; ALT AST ≤ 2.5 x ULN Serum creatinine ≤ 1.5 x ULN calculate creatinine clearance &gt; 50 ml/min ; Prothrombin time INR &lt; 1.5 x ULN ; Activated partial thromboplastin time &lt; 1.25 x ULN ( therapeutic anticoagulation therapy allow treatment interrupt judge treat physician ) Written informed consent Lesion &gt; 3,5 cm size ; History epilepsy ; Extrahepatic metastasis render local therapy unfeasible ; History cardiac disease : Congestive heart failure &gt; NYHA class 2 ; Active Coronary Artery Disease ( define myocardial infarction within 6 month prior screen ) ; Cardiac arrhythmia require antiarrhythmic therapy pacemaker ( beta blocker permit ) ; Uncontrolled hypertension . Blood pressure must ≤160/95 mmHg time screen stable antihypertensive regimen ; Compromised liver function ( e.g . sign portal hypertension , INR &gt; 1,5 without use anticoagulant , ascites ) ; Pregnant breastfeeding subject ; Immunotherapy ≤ 6 week prior procedure ; Chemotherapy ≤ 6 week prior procedure ; Concomitant use anticonvulsives antiarrhythmic drug beta blocker antiepileptic antiarrhythmic purpose ; Allergy contrast medium ; Any implant stimulation device ; Any condition unstable could jeopardize safety subject compliance study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Colorectal liver metastasis ( CRLM )</keyword>
	<keyword>Tumor ablation</keyword>
	<keyword>Irreversible electroporation ( IRE )</keyword>
	<keyword>Interventional oncology</keyword>
	<keyword>NanoKnife</keyword>
	<keyword>Colorectal liver metastasis , unresectable not-thermally ablative due location near vulnerable structure like vessel bile duct</keyword>
</DOC>